Literature DB >> 5157136

Changes of the smooth endoplasmic reticulum induced by rifampicin in human and guinea-pig hepatocytes.

A M Jezequel, F Orlandi, L T Tenconi.   

Abstract

Rifampicin induces a proliferation of the smooth endoplasmic reticulum in guinea-pig and human hepatocytes. This may support the hypothesis of enhancement of drug-metabolizing enzymes induced by the drug. However, the pattern of proliferation is not similar in man and in guinea-pig hepatocytes. Some caution is needed in the study of enzyme induction in man and in extrapolations from animal to human data.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5157136      PMCID: PMC1412001          DOI: 10.1136/gut.12.12.984

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

Review 1.  Organelle pathology of the liver. The endoplasmic reticulum.

Authors:  R J Stenger
Journal:  Gastroenterology       Date:  1970-04       Impact factor: 22.682

2.  The normal human liver cell. Cytochemical and ultrastructural studies.

Authors:  M H Ma; L Biempica
Journal:  Am J Pathol       Date:  1971-03       Impact factor: 4.307

3.  [Pharmacokinetics of rifomycin].

Authors:  G Curci; A Ninni; F Iodice
Journal:  Acta Tuberc Pneumol Belg       Date:  1969

4.  Reduction in serum bilirubin by phenobarbital in adult unconjugated hyperhilirubinaemia. Is enzyme induction responsible?

Authors:  M J Whelton; L P Krustev; B H Billing
Journal:  Am J Med       Date:  1968-07       Impact factor: 4.965

5.  The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in man.

Authors:  G Acocella; F B Nicolis; L T Tenconi
Journal:  Gastroenterology       Date:  1965-11       Impact factor: 22.682

6.  The effect of rifamycin SV on pigment excretion in rats.

Authors:  G Acocella; B H Billing
Journal:  Gastroenterology       Date:  1965-11       Impact factor: 22.682

Review 7.  Chemical and biological properties of rifampicin.

Authors:  S Furesz
Journal:  Antibiot Chemother       Date:  1970

8.  Ethanol increases hepatic smooth endoplasmic reticulum and drug-metabolizing enzymes.

Authors:  E Rubin; F Hutterer; C S Lieber
Journal:  Science       Date:  1968-03-29       Impact factor: 47.728

9.  Effect of sodium phenobarbital on bilirubin metabolism in an infant with congenital, nonhemolytic, unconjugated hyperbilirubinemia, and kernicterus.

Authors:  J F Crigler; N I Gold
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

10.  Hepatic microsomal enzymes in man and rat: induction and inhibition by ethanol.

Authors:  E Rubin; C S Lieber
Journal:  Science       Date:  1968-11-08       Impact factor: 47.728

View more
  23 in total

1.  Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.

Authors:  W Zilly; D D Breimer; E Richter
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

Review 2.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

3.  Possible implications of doxycycline-rifampin interaction for treatment of brucellosis.

Authors:  J D Colmenero; L C Fernández-Gallardo; J A Agúndez; J Sedeño; J Benítez; E Valverde
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

4.  Serum concentrations and bioavailability of rifampicin and isoniazid in combination.

Authors:  J C Garnham; T Taylor; P Turner; L F Chasseaud
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

5.  Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients.

Authors:  M H Chandler; S M Toler; R P Rapp; R R Muder; J A Korvick
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

6.  Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance.

Authors:  W Zilly; D D Breimer; E Richter
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

7.  Alterations of glucocorticoid actions by other drugs and disease states.

Authors:  W Jubiz; A W Meikle
Journal:  Drugs       Date:  1979-08       Impact factor: 9.546

8.  Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid.

Authors:  G Boman
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

9.  [Postmortem evaluation of barbiturate poisonings].

Authors:  A Schmoldt; E R Beckmann; W Horstmann
Journal:  Z Rechtsmed       Date:  1984

Review 10.  Clinical pharmacokinetics of rifampicin.

Authors:  G Acocella
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.